RELIABLE BIOPHARMACEUTICAL, LLC – Trademark Portfolio
Entity Type: 16
RELIABLE BIOPHARMACEUTICAL, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include R RELIABLE BIOPHARMACEUTICAL. The owner is based in RADNOR, PA.
RADNOR CORPORATE CENTER, 100 MATSONFORD
ROAD BUILDING ONE, SUITE 200
RADNOR, PA 19087
Showing of trademarks Trademarks
Trademark Classifications
RELIABLE BIOPHARMACEUTICAL, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does RELIABLE BIOPHARMACEUTICAL, LLC have?
RELIABLE BIOPHARMACEUTICAL, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does RELIABLE BIOPHARMACEUTICAL, LLC file in?
RELIABLE BIOPHARMACEUTICAL, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are RELIABLE BIOPHARMACEUTICAL, LLC's most well-known trademarks?
RELIABLE BIOPHARMACEUTICAL, LLC's registered trademark portfolio includes well-known marks such as R RELIABLE BIOPHARMACEUTICAL. These are among 1 currently registered trademark in the portfolio.
What is RELIABLE BIOPHARMACEUTICAL, LLC's trademark registration success rate?
RELIABLE BIOPHARMACEUTICAL, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.